摘要 |
This invention provides compounds of formula I, having the structure wherein R<SUB>1</SUB>, R<SUB>4</SUB>, A, and Z are as defined in the specification, or a pharmaceutically acceptable salt thereof, that are useful in treating metabolic disorders mediated by insulin resistance or hyperglycemia.
|